111 related articles for article (PubMed ID: 23400852)
1. Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cells.
Pajtler KW; Rebmann V; Lindemann M; Schulte JH; Schulte S; Stauder M; Leuschner I; Schmid KW; Köhl U; Schramm A; Eggert A
Int J Cancer; 2013 Aug; 133(4):908-19. PubMed ID: 23400852
[TBL] [Abstract][Full Text] [Related]
2. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
[TBL] [Abstract][Full Text] [Related]
3. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
Schulte JH; Schramm A; Klein-Hitpass L; Klenk M; Wessels H; Hauffa BP; Eils J; Eils R; Brodeur GM; Schweigerer L; Havers W; Eggert A
Oncogene; 2005 Jan; 24(1):165-77. PubMed ID: 15637590
[TBL] [Abstract][Full Text] [Related]
4. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.
Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM
Cancer Res; 2002 Mar; 62(6):1802-8. PubMed ID: 11912158
[TBL] [Abstract][Full Text] [Related]
5. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells.
Pajtler KW; Mahlow E; Odersky A; Lindner S; Stephan H; Bendix I; Eggert A; Schramm A; Schulte JH
Oncotarget; 2014 Nov; 5(22):11180-92. PubMed ID: 25361003
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.
Higashi M; Kolla V; Iyer R; Naraparaju K; Zhuang T; Kolla S; Brodeur GM
Mol Cancer; 2015 Aug; 14():150. PubMed ID: 26245651
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells.
Kim CJ; Matsuo T; Lee KH; Thiele CJ
Am J Pathol; 1999 Nov; 155(5):1661-70. PubMed ID: 10550322
[TBL] [Abstract][Full Text] [Related]
9. Invariant chain+ N2a neuroblastoma cells stably expressing the class II MHC transactivator CIITA fail to stimulate anti-tumor immunity.
Rickard S; Ono SJ
Exp Mol Pathol; 2008 Dec; 85(3):147-54. PubMed ID: 18952077
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
Kramer K; Gerald W; LeSauteur L; Uri Saragovi H; Cheung NK
Clin Cancer Res; 1996 Aug; 2(8):1361-7. PubMed ID: 9816308
[TBL] [Abstract][Full Text] [Related]
11. [Receptor tyrosine kinase KIT may regulate expression of genes involved in spontaneous regression of neuroblastoma].
Lebedev TD; Spirin PV; Suntsova MV; Ivanova AV; Buzdin AA; Prokofjeva MM; Rubtsov PM; Prassolov VS
Mol Biol (Mosk); 2015; 49(6):1052-5. PubMed ID: 26710790
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Brodeur GM
Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
[TBL] [Abstract][Full Text] [Related]
13. Expression of neurotrophin receptor TrkA inhibits angiogenesis in neuroblastoma.
Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM
Med Pediatr Oncol; 2000 Dec; 35(6):569-72. PubMed ID: 11107119
[TBL] [Abstract][Full Text] [Related]
14. Rotary bioreactor culture can discern specific behavior phenotypes in Trk-null and Trk-expressing neuroblastoma cell lines.
Redden RA; Iyer R; Brodeur GM; Doolin EJ
In Vitro Cell Dev Biol Anim; 2014 Mar; 50(3):188-93. PubMed ID: 24477561
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of TrkA protein expression by miRNA‑92a promotes the proliferation and migration of human neuroblastoma cells.
Liao W; Zhang H; Feng C; Wang T; Zhang Y; Tang S
Mol Med Rep; 2014 Aug; 10(2):778-84. PubMed ID: 24839961
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
[TBL] [Abstract][Full Text] [Related]
18. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
[TBL] [Abstract][Full Text] [Related]
19. IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.
Kloess S; Huenecke S; Piechulek D; Esser R; Koch J; Brehm C; Soerensen J; Gardlowski T; Brinkmann A; Bader P; Passweg J; Klingebiel T; Schwabe D; Koehl U
Eur J Immunol; 2010 Nov; 40(11):3255-67. PubMed ID: 21061445
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-II expression is down-regulated in TrkA-transfected SK-N-AS neuroblastoma cells.
Kim CJ; Chi JG; Thiele CJ
Lab Invest; 1999 Aug; 79(8):1007-13. PubMed ID: 10462038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
